Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Seroprevalence of Antibodies to Burkholderia pseudomallei in Mississippi Gulf Coast Residents, September 2023

Seroprevalence of Antibodies to Burkholderia pseudomallei in Mississippi Gulf Coast Residents, September 2023

Authors: DeBord KM, Elrod MG, Hartloge C, Meyer WA 3rd, Swanson BE, Schrodt CA, Negron ME, Weiner ZP

Citation: Pathogens. 2025 Sep 12;14(9):921. doi: 10.3390/pathogens14090921

Specialties: Infectious disease

Related content

Publication
Increased Odds of Antibiotic Resistance in E. coli Isolates from Recurrent Urinary Tract Infections
Publication
Utility and recommendations for the use of multiplex molecular gastrointestinal pathogen panels
Audio Podcast
The power of laboratory analytics
Test FAQ
Diagnosis of Intestinal Parasites
Publication
Viral Pathogen Detection Using Multiplex Gastrointestinal Molecular Panels: The Pros and Cons of Viral Target Inclusion

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.